Immunic AG | Finanzwire

Basculer en Français

8296	Companies
114899	Keywords
55320	Articles
62454	Press releases

Home
Companies
Immunic AG

BRIEF

published on 04/30/2024 at 12:35, 6 months 21 days ago

Immunic Highlights Extended Data from EMPhASIS Trial in Peer-Reviewed Journal

Vidofludimus Calcium EMPhASIS Trial Relapsing-remitting Multiple Sclerosis Neuroprotection Immune Modulation
PRESS RELEASE

published on 04/30/2024 at 12:30, 6 months 21 days ago

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in RRMS in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
Immunic announces publication of extended data from phase 2 EMPhASIS trial of Vidofludimus Calcium in RRMS in Neurology Neuroimmunology & Neuroinflammation journal

Immunic Vidofludimus Calcium EMPhASIS Trial Neurology Journal RRMS
BRIEF

published on 04/04/2024 at 12:35, 7 months 17 days ago

Immunic to Participate in Upcoming MS Research Day and Investor Conferences

Biotechnology Investor Conferences Immunic Vidofludimus Calcium MS Research
PRESS RELEASE

published on 04/04/2024 at 12:30, 7 months 17 days ago

Immunic to Host MS R&D Day and Participate in Investor Conferences in April
Immunic, Inc. to host Multiple Sclerosis (MS) Research and Development (R&D) Day and participate in investor conferences in April, showcasing latest developments and clinical data

Investor Conferences Immunic Inc. Clinical Pipeline Multiple Sclerosis R&D Day
BRIEF

published on 03/20/2024 at 11:35, 8 months 1 day ago

Immunic Secures U.S. Patent Allowance for Novel Vidofludimus Calcium Formulation

Intellectual Property Immunic Vidofludimus Calcium Autoimmune Diseases Polymer Patent
PRESS RELEASE

published on 03/20/2024 at 11:30, 8 months 1 day ago

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
Immunic receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States, enhancing intellectual property protection

Patent Intellectual Property Immunic Vidofludimus Calcium Notice Of Allowance

Accesswire

Published on 11/21/2024 at 13:00, 26 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 26 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 26 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 11 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 51 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 11 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 19 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 26 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 28 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 6 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE